Could This NEW RSV Vaccine Save Your Child? Shocking Benefits Revealed! Don't Miss Out!

The Public Health Agency (PHA) is urging eligible individuals to receive the Respiratory Syncytial Virus (RSV) vaccination, as the criteria for vaccination eligibility have recently expanded. This push comes in response to the potential for serious complications associated with RSV, a respiratory virus that can be particularly dangerous for young children and older adults.

Starting April 1, 2026, all adults aged 80 years and older will be eligible for the RSV vaccination and will receive invites from their GP practices. This expansion adds to existing eligibility that includes adults between the ages of 75 and 79, pregnant women, and all residents of care homes for older adults, regardless of age. The goal is to increase protection against RSV, which can lead to severe respiratory issues in vulnerable populations.

Rachel Spiers, Senior Commissioning Lead for Immunisations at the PHA, highlighted the significance of this initiative, stating, "RSV is a common and highly infectious respiratory virus that affects the breathing system, particularly in young children and older adults. RSV infections often lead to mild cold-like symptoms, but in some cases, especially in infants and individuals with compromised immune systems, it can cause severe respiratory issues such as bronchiolitis and pneumonia, which often require hospitalization."

In 2025, the impact of RSV was notably significant, with 476 episodes reported in infants under one year and 195 episodes in individuals aged 75 and older. Alarmingly, 335 infants under one year and 130 individuals aged 75 and older were hospitalized due to RSV complications during that same year. The data underscores the importance of vaccination as a preventative measure.

Health Minister Mike Nesbitt has endorsed the expansion of the RSV vaccination program, stating, "I have approved the expansion of the RSV vaccination program, which builds on the adult program in place since 2024. There is also a maternal RSV vaccination program available for all pregnant women aimed at protecting their newborn babies." He encourages all eligible individuals to accept the vaccination when offered, emphasizing that it serves as a key tool for protecting against illness.

Vaccination in Northern Ireland is now available to:

• Adults aged 80 years and over

This expands upon the existing groups eligible for RSV vaccination, which include:

• Residents in care homes for older adults
• Adults turning 75 years
• Adults aged 75 to 79 years when the program began
• Pregnant women (to protect their babies after they are born)

For older adults who have not yet received an RSV vaccination and are over the age of 75, GP practices will extend invitations. Residents in care homes and those who are housebound will receive vaccinations from their local Health and Social Care (HSC) Trust vaccination teams. Additionally, those eligible for both RSV and spring COVID-19 vaccinations may be offered both at the same time by their GP once the spring 2026 COVID-19 campaign launches on April 13, 2026, following Joint Committee on Vaccination and Immunisation (JCVI) guidance.

The program for pregnant women remains unchanged; they will be offered the vaccine during antenatal appointments with their midwives starting at 28 weeks into their pregnancies. This schedule is designed to provide protection for newborns against severe illness caused by RSV infections.

In closing, Rachel Spiers asserted, “The virus spreads through respiratory droplets, making it easily transmissible, especially in crowded settings. This vaccination program will help protect some of those who are most at risk from getting an RSV infection. If you are eligible, I would strongly encourage you to get vaccinated to give yourself or your newborn the best protection from RSV and any potentially serious illness it can bring.”

For more information on the RSV vaccine for adults, visit www.pha.site/immunisation-and-vaccinations.